Healios Launches Medical Materials Division to Boost Culture Supernatant Supply

MT Newswires Live

2025/01/20

Healios K.K (TYO:4593) has launched a medical materials and equipment division to secure a steady supply of culture supernatant and expand its business, according to a Friday filing on the Tokyo Stock Exchange.

The division will manage production, quality control, and regulatory compliance, and support market research and customer engagement.

This follows Healios' partnership with AND medical group to supply culture supernatant for new treatments and cosmetics. Healios is also seeking conditional approval in Japan for its MultiStem therapy targeting acute respiratory distress syndrome (ARDS).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2504739413"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2504739413\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2504739413?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-20 07:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2504739413","market":"nz","top_or_hot":-1,"title":"Healios Launches Medical Materials Division to Boost Culture Supernatant Supply","media":"MT Newswires Live","content":"<html><body><p> Healios K.K (TYO:4593) has launched a medical materials and equipment division to secure a steady supply of culture supernatant and expand its business, according to a Friday filing on the Tokyo Stock Exchange.</p><p>The division will manage production, quality control, and regulatory compliance, and support market research and customer engagement.</p><p>This follows Healios' partnership with AND medical group to supply culture supernatant for new treatments and cosmetics. Healios is also seeking conditional approval in Japan for its MultiStem therapy targeting acute respiratory distress syndrome (ARDS).</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healios Launches Medical Materials Division to Boost Culture Supernatant Supply</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealios Launches Medical Materials Division to Boost Culture Supernatant Supply\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-20 07:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Healios K.K (TYO:4593) has launched a medical materials and equipment division to secure a steady supply of culture supernatant and expand its business, according to a Friday filing on the Tokyo Stock Exchange.</p><p>The division will manage production, quality control, and regulatory compliance, and support market research and customer engagement.</p><p>This follows Healios' partnership with AND medical group to supply culture supernatant for new treatments and cosmetics. Healios is also seeking conditional approval in Japan for its MultiStem therapy targeting acute respiratory distress syndrome (ARDS).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARKG","symbol_name":"ARK Genomic Revolution ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2504739413","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2504739413","pubTimestamp":1737328226,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Healios K.K  has launched a medical materials and equipment division to secure a steady supply of culture supernatant and expand its business, according to a Friday filing on the Tokyo Stock Exchange.The division will manage production, quality control, and regulatory compliance, and support market research and customer engagement.This follows Healios' partnership with AND medical group to supply culture supernatant for new treatments and cosmetics. Healios is also seeking conditional approval in Japan for its MultiStem therapy targeting acute respiratory distress syndrome .","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","BK4139":"生物科技","ARDS":"Aridis制药","BK4544":"ARK ETF合集","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"Healios成立医疗材料部门以增加培养上清液供应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDS":1,"ARKG":1},"content_text":"Healios K.K (TYO:4593) has launched a medical materials and equipment division to secure a steady supply of culture supernatant and expand its business, according to a Friday filing on the Tokyo Stock Exchange.The division will manage production, quality control, and regulatory compliance, and support market research and customer engagement.This follows Healios' partnership with AND medical group to supply culture supernatant for new treatments and cosmetics. Healios is also seeking conditional approval in Japan for its MultiStem therapy targeting acute respiratory distress syndrome (ARDS).","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}